ArticleMaterials advances2026
Plasma enhanced vapor deposition of dipeptide nanostructures: nanotubes to nanoflowers.
Article in Materials advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The study of self-assembling peptides for synthesizing nanomaterials is a rapidly growing area in biomedical research. In this study, we report a hybrid deposition technique, plasma enhanced chemical vapor deposition (PECVD), as a reliable method for the synthesis of aromatic tyrosine peptide-based nanostructures with well-defined structural and physicochemical properties. In the custom-built PECVD system, deposition parameters, including the deposition height, substrate tilt, chamber pressure, frequency of plasma pulsation, and presence of physical confinement, were varied, leading to the formation of thin films with desired morphologies, uniformity, and stability. Morphological characterization revealed that the conditions during deposition could be varied to form nanotubular-like structures, whereas higher pressure and the presence of physical confinement led to the emergence of nanoflower-like structures. Nanoflowers are nanostructures with a high surface area-to-volume ratio and a large number of effective sites featuring multilayered porous "petal" structures that extend radially from centralized nucleation sites. Spectroscopic analysis confirmed the simultaneous preservation of peptide chemistry, alterations in the secondary structure, and increased crystallinity, suggesting molecular reorganization. These results provide insights into the plethora of opportunities offered by PECVD for applications in catalytic substrates, regenerative medicine, targeted drug delivery, and the development of antimicrobial coatings.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.